The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2024

Filed:

Jan. 14, 2022
Applicant:

Diffusion Rx, Inc., Riverside, CT (US);

Inventors:

Robert N. Hotchkiss, Riverside, CT (US);

Paul Ashton, San Diego, CA (US);

Martin Nazzaro, Quincy, MA (US);

Assignee:

Diffusion RX, Inc., Riverside, CT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/54 (2006.01); A61F 2/28 (2006.01); A61F 2/30 (2006.01); A61K 31/573 (2006.01); A61L 27/06 (2006.01); A61L 27/18 (2006.01);
U.S. Cl.
CPC ...
A61L 27/54 (2013.01); A61F 2/28 (2013.01); A61K 31/573 (2013.01); A61L 27/06 (2013.01); A61L 27/18 (2013.01); A61F 2002/2825 (2013.01); A61F 2002/3021 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/3085 (2013.01); A61F 2002/30884 (2013.01); A61F 2310/00023 (2013.01); A61L 2430/02 (2013.01); A61L 2430/24 (2013.01);
Abstract

Provided herein are devices and methods for treating inflammation and pain of articular joints (e.g., the knee). An implantable device includes an elongate body extending from a proximal end to a distal end, a flange disposed at the proximal end, a bore extending from an opening at the proximal end into the elongate body, one or more fixation members disposed on an outer surface of the elongate body, and a payload (e.g., a drug-polymer core) having a therapeutic agent disposed within the bore. The payload has a substantially constant surface area on an exposed portion throughout elution of the therapeutic agent after the implantable device is implanted in a body. The therapeutic agent is configured to elute using zero-order kinetics, constantly and continuously at an amount that is above a predetermined lower threshold and does not exceed a predetermined upper threshold unlike a pulse-dose injection.


Find Patent Forward Citations

Loading…